Skip to main content
Clinical Trials/NL-OMON23067
NL-OMON23067
Completed
Not Applicable

Tissue oxygenation and perfusion and the determination of glucose subcutaneously.

P.H.J. van der Voort, MD, PhDOnze Lieve Vrouwen GasthuisOosterpark 9, 1091 AC Amsterdam, the NetherlandsEmail: p.h.j.vandervoort@olvg.nl0 sites60 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
continuous glucose monitoring (continue glucose monitoring)microcirculation (microcirculatie)intensive care unit (intensive care)cardiothoracic surgery (cardiothoracale chirurgie)
Sponsor
P.H.J. van der Voort, MD, PhDOnze Lieve Vrouwen GasthuisOosterpark 9, 1091 AC Amsterdam, the NetherlandsEmail: p.h.j.vandervoort@olvg.nl
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
P.H.J. van der Voort, MD, PhDOnze Lieve Vrouwen GasthuisOosterpark 9, 1091 AC Amsterdam, the NetherlandsEmail: p.h.j.vandervoort@olvg.nl

Eligibility Criteria

Inclusion Criteria

  • 1\. Admission to the hospital for elective open cardiac surgery (coronaty artery bypass graftl mitral\-, tricuspidal\- and aortic valve surgery);
  • 2\. Age 18\-85 years;

Exclusion Criteria

  • Abdominal abnormalities that inhibit sensor insertion.

Outcomes

Primary Outcomes

Not specified

Similar Trials